Tang Capital Management as of June 30, 2016
Portfolio Holdings for Tang Capital Management
Tang Capital Management holds 12 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Heron Therapeutics (HRTX) | 49.8 | $112M | 6.2M | 18.05 | |
| La Jolla Pharmaceuticl Com Par | 21.8 | $49M | 3.1M | 16.00 | |
| Ignyta | 9.6 | $22M | 4.0M | 5.42 | |
| Opko Health Inc note 3.0% 2/1/33 | 8.8 | $20M | 14M | 1.41 | |
| BioMarin Pharmaceutical (BMRN) | 3.1 | $7.0M | 90k | 77.80 | |
| Alibaba Group Holding (BABA) | 2.1 | $4.8M | 60k | 79.53 | |
| Merrimack Pharmaceuticals In note 4.500% 7/1 | 1.8 | $4.0M | 3.5M | 1.13 | |
| Nektar Therapeutics (NKTR) | 1.6 | $3.7M | 260k | 14.23 | |
| BioCryst Pharmaceuticals (BCRX) | 0.5 | $1.2M | 430k | 2.84 | |
| Lipocine | 0.3 | $790k | 260k | 3.04 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 0.3 | $777k | 279k | 2.78 | |
| Celldex Therapeutics | 0.1 | $220k | 50k | 4.40 |
